With coronavirus having obvious impacts on the entire events industry during the majority of 2020 and 2021, what remains to be seen is whether any benefits have come from these unprecedented times, whether any lessons have been learned, and what long term trends can we expect to see in the events landscape beyond the pandemic.
From March last year, all event types, from sports and live music to conferences and trade shows, were either postponed or cancelled indefinitely. With revenue streams in most industries taking a huge hit, cost-cutting practices have become even more of an…
Panel
Flic Gabbay, tranScrip (Chair)
Lisa Urquhart, Vantage
Bartlomiej Janac (Bart), Charles River Laboratories
Claire Thompson, Agility Life Sciences
Flic Gabbay, chairing the session, describes how each of the panellists collectively offer a ‘flavour’ of different organisations and perspectives but complement each other nicely when discussing such a topic. Flic starts off by introducing, tranScrip, and explains what ESG means to them when put into practice. Recently, tranScrip had been invested in by a Social Impact Fund which required them to have ESG KPIs (Key Performance…
Following on from a successful Building Life Sciences Adventures careers conference, our April 2021 My Question Is…Networking Lunch was dedicated to continuing discussions that arose from the conference. I am delighted to have the opportunity to blog about the outputs from this session and to keep the conversation going. As usual, we asked our network to pose the questions that were important to them. So, without further ado, let’s kick off with the questions…
Question one submitted by Claire Russell, Royal Veterinary College: “What would encourage companies to take on…
Here at Giggabox, we are extremely proud to announce that we have been chosen to power British Chambers of Commerce’s flagship event. Being one of the main events in the business calendar, the British Chambers of Commerce Global Annual Conference 2021 will take place on 16th and 17th June. This two-day Virtual Event will feature a host of influential business leaders, politicians and policy experts, and stream to thousands of attendees from all over the globe.
Paul Musselle, CEO of Giggabox, commented “We’re absolutely delighted that British Chambers of Commerce is placing its faith in us to…
Panel
Maria Herva Moyano, Charles River Laboratories (Chair)
Elisabeth Goodman, RiverRhee Consulting
Jeroen Stam, Norwich Bioscience Institutes (NBI)
David Cronk, Domainex
Alex Spicer, Faron
This was the first session of the Building Life Science Adventures conference and it certainly did not disappoint! Maria Herva Moyano (Mariu), Chairing the discussion, introduced herself and the other panellists Jeroen Stam, David Cronk, Alex Spicer and Elisabeth Goodman followed suit, including what they felt they would contribute to the panel. They covered all corners ranging from being a coach, a team…
Panel
Ricky Martin, HRS (Chair)
Nadia Shivji-Brown, Public Health England (PHE)
Andrew Carr, Charles River Laboratories (CRL)
Renos Savva, Birkbeck, University of London
Ricky opened the discussion by asking the panel “what does investing in personal R&D mean to you?”. Andrew Carr (Andy) began by sharing one of his personal experiences about how he has had to retrain twice during his career to get to where he is today at CRL, once scientifically and the second time as a manager to learn how to be responsible and support the people who work for him. A valuable piece of advice was…
In recent years Contract Research Organisations (CROs) have become the backbone of pharma and biotech research and development (R&D), the go-to source for in-depth know-how and niche expertise no longer available within such organisations. Despite being squeezed hard by COVID-19, according to new analysis out by Frost and Sullivan, the global market should still grow to $63.83 billion by 2024 from $43.03 billion in 2019, at a compound annual growth rate of 8.2%.
The growth of the global CRO market has been primarily driven by increased big pharma outsourced development spend and the…
Recognise this? It’s a common sight in many research facilities across the world: container after container filled with important biological samples. It may mean it’s time to upgrade from containers to a better, long-term solution.
Often, research projects or sample storage facilities will start small, using just one or two containers - often referred to as ‘dewars’ - to store a few samples. As the facility grows, more and more containers are added until you have a makeshift cryo-room which probably looks something like the above image.
Samples are generally never thrown away by researchers…
During our careers, the opportunity to work on something genuinely ground-breaking, something pioneering that raises the bar, is extremely rare. In October, the Kao Data team was contacted by NVIDIA regarding their Cambridge-1 project. As soon as we saw the plans for the UK’s most powerful supercomputer, we were hooked.
Collaborating with NVIDIA comes with an expectation that you’ll be operating alongside some of the smartest minds in the industry; that innovation is everything and that you’ll be performing at pace. Supercharged pace. NVIDIA’s Cambridge-1 project has exceeded those…
Once again, One Nucleus held a really useful and informative session whereby an intimate group of attendees gathered to discuss thought-provoking questions posed by the One Nucleus community. Discussions each take place in individual breakout groups, but so the key take-aways can be disseminated more widely, this wrap-up serves to provide an overview of all discussions. Therefore, regardless of the breakout group individuals were in, the insights are shared amongst all.
Question one submitted by Fay Weston, Independent: “How important is ESG/CSR reporting going to become in the UK…